The 61st Annual Thomas L. Petty Aspen Lung Conference
In-Person Event
Jun 06 - 09, 2018
Aspen, Colorado, USAOVERVIEW
The 61st Annual Thomas L. Petty Aspen Lung Conference is organized by Pulmonary Sciences and Critical Care Medicine and will be held during Jun 06 - 09, 2018 at The Gant, Aspen, Colorado, United States of America.
The target audience for this medical event is Local/Regional/National/International Physicians/Clinicians (adult and pediatric)/Research Physician-Scientists in Pulmonary Sciences, Critical Care and Sleep Medicine/Primary Care Physicians/General Medicine Physicians/Public Health.
Conference Description:
Chronic obstructive pulmonary disease (COPD) is the 3rd leading cause of death in the United States and the 4th leading cause of death worldwide. Despite progress, current therapies only mitigate symptoms and have no clear effect on mortality or the long-term decline in lung function.
Understanding the pathophysiology of COPD, developing novel treatment strategies, and effectively implementing lung-reparative therapeutics would be expected to have a significant impact on COPD, as well as other pulmonary diseases.
With an emphasis on the integration of basic, translational, and clinical approaches, the 2018 conference focuses on a central question: how can knowledge of resilience or susceptibility to develop COPD be translated into more effective therapies?
To address this central question, we have organized the program into a series of thematic sessions framed by a Keynote Address, Clinical Perspective, and NHLBI Perspective. The thematic sessions focus on the following:
• Clinical and molecular heterogeneity of COPD
• COPD as a disease of accelerated aging
• Stem cell dysfunction and regenerative therapies for COPD
• Immune and epithelial cell mechanisms of COPD exacerbations
• Metabolic and biochemical mechanisms of COPD pathogenesis
• Consequences of COPD beyond the obstructed lung
Learning Objectives:
The Aspen Lung Conference seeks to accomplish the following objectives:
• To provide an international forum for leading basic, translational, and clinical researchers to exchange ideas regarding fundamental concepts underlying susceptibility and resistance to develop COPD.
• To stimulate interactions between the fields of phenotype/endotypes, genomics/epigenetics, aging, stem cell biology, metabolism and lipid biochemistry with the goal of identifying emerging, shared interests that may lead to the performance of more efficient and productive research.
• To advance our understanding of clinical and molecular COPD phenotypes/endotypes that predict risk or response in order to quickly translate preclinical findings to more effective, personalized therapies.
• To challenge and thereby stimulate the scientific interests of trainees, attracting a new generation of junior investigators into the field of COPD pathobiology.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Local/Regional/National/International Physicians/Clinicians (adult and pediatric)/Research Physician-Scientists in Pulmonary Sciences, Critical Care and Sleep Medicine/Primary Care Physicians/General Medicine Physicians/Public Health.
Conference Description:
Chronic obstructive pulmonary disease (COPD) is the 3rd leading cause of death in the United States and the 4th leading cause of death worldwide. Despite progress, current therapies only mitigate symptoms and have no clear effect on mortality or the long-term decline in lung function.
Understanding the pathophysiology of COPD, developing novel treatment strategies, and effectively implementing lung-reparative therapeutics would be expected to have a significant impact on COPD, as well as other pulmonary diseases.
With an emphasis on the integration of basic, translational, and clinical approaches, the 2018 conference focuses on a central question: how can knowledge of resilience or susceptibility to develop COPD be translated into more effective therapies?
To address this central question, we have organized the program into a series of thematic sessions framed by a Keynote Address, Clinical Perspective, and NHLBI Perspective. The thematic sessions focus on the following:
• Clinical and molecular heterogeneity of COPD
• COPD as a disease of accelerated aging
• Stem cell dysfunction and regenerative therapies for COPD
• Immune and epithelial cell mechanisms of COPD exacerbations
• Metabolic and biochemical mechanisms of COPD pathogenesis
• Consequences of COPD beyond the obstructed lung
Learning Objectives:
The Aspen Lung Conference seeks to accomplish the following objectives:
• To provide an international forum for leading basic, translational, and clinical researchers to exchange ideas regarding fundamental concepts underlying susceptibility and resistance to develop COPD.
• To stimulate interactions between the fields of phenotype/endotypes, genomics/epigenetics, aging, stem cell biology, metabolism and lipid biochemistry with the goal of identifying emerging, shared interests that may lead to the performance of more efficient and productive research.
• To advance our understanding of clinical and molecular COPD phenotypes/endotypes that predict risk or response in order to quickly translate preclinical findings to more effective, personalized therapies.
• To challenge and thereby stimulate the scientific interests of trainees, attracting a new generation of junior investigators into the field of COPD pathobiology.
Additional details will be posted as soon as they are available.
KEY DATES
06 Jun, 2018
Event Start Date
09 Jun, 2018
Event End Date
SPECIALITIES
Pulmonary MedicineSUGGESTED HOTELS
CONFERENCE VENUE
The GantRELATED CONFERENCES & LIVE WEBINARS
Quick Links